RxDoctor Payments Data

Charles Elliott, MD

Otolaryngology · Kokomo, INNPI 1144226317

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Spirair, Inc. accounts for 60.3% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $9,608, more than ten times the $618 reported in 2019. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,580in general payments, 2019–2025

Across 129 payments — averaging $128.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spirair, Inc.$10K
  • Aerin Medical Inc.$4K
  • Stryker$739
  • Acclarent, Inc$659
  • AstraZeneca$386
  • Integra Lifesciences Corporation$315
  • plus $631 from 13 others

What the payments were for

  • Consulting fees$7,50045%
  • Travel & lodging$7284%
  • Food & beverage$8,35350%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,580 in reported general payments places this provider in the 90th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$69,804
Medicare patients
215
Services billed
554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth34$4,149
Mometasone Furoate17$715
Cephalexin116$605
Fluticasone Propionate13$222
Clindamycin Hcl32$210
ErythromycinErythromycin Base16$194
Methylprednisolone17$71
Mupirocin12$70
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$53
Fluconazole11$47

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Kokomo

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →